Alphatec Holdings (ATEC) Non-Current Debt (2010 - 2026)
Alphatec Holdings (ATEC) posted Non-Current Debt of $507.9 million for Q1 2026, up 1.29% sequentially from $501.4 million in Q4 2025, and down 6.95% YoY from $545.8 million in Q1 2025.
Alphatec Holdings (ATEC) Non-Current Debt (2010 - 2026) Analysis & Trends
Alphatec Holdings has reported Non-Current Debt for 17 years, with the latest figure at $507.9 million in Q1 2026.
- Quarterly Non-Current Debt fell 6.95% year-over-year to $507.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $507.9 million (down 6.95% YoY) and the FY2025 annual result came in at $501.4 million, down 12.73% from the prior year.
- Non-Current Debt climbed to $507.9 million in Q1 2026 per ATEC's latest filing, from $501.4 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $574.5 million in Q4 2024 and troughed at $313.4 million in Q2 2022.
- A 5-year average of $468.3 million and a median of $506.6 million in 2023 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2022 and 2025: Non-Current Debt soared 746.65% in 2022, then retreated 12.73% in 2025.
- Over 5 years, Non-Current Debt stood at $349.5 million in 2022, then jumped by 46.21% to $511.0 million in 2023, then grew by 12.42% to $574.5 million in 2024, then declined by 12.73% to $501.4 million in 2025, then grew by 1.29% to $507.9 million in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $507.9 million, $501.4 million, and $495.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Alphatec Holdings | 1.45 Bn | 1.34 Bn | 154.10 Mn | 510.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 510.74 Mn |
| Mar 31, 2026 | 507.89 Mn |
| Dec 31, 2025 | 501.41 Mn |
| Sep 30, 2025 | 495.02 Mn |
| Jun 30, 2025 | 551.99 Mn |
| Mar 31, 2025 | 545.83 Mn |
| Dec 31, 2024 | 574.52 Mn |
| Sep 30, 2024 | 525.94 Mn |
| Jun 30, 2024 | 516.88 Mn |
| Mar 31, 2024 | 511.89 Mn |
| Dec 31, 2023 | 511.04 Mn |
| Sep 30, 2023 | 506.61 Mn |
| Jun 30, 2023 | 455.34 Mn |
| Mar 31, 2023 | 419.46 Mn |
| Dec 31, 2022 | 349.51 Mn |
| Sep 30, 2022 | 348.32 Mn |
| Jun 30, 2022 | 313.40 Mn |
| Mar 31, 2022 | 326.64 Mn |
| Dec 31, 2021 | 326.49 Mn |
| Sep 30, 2021 | 320.97 Mn |